Loading
FORT MYERS — Cancer treatment firm 21st Century Oncology says it will delay filing its latest financial results and warned investors that its lenders may consider it in default.
In a filing with the Securities and Exchange Commission on Friday, 21st Century Oncology says the delay in reporting the annual financial results for 2015 and the first quarter of 2016 by the July 31 deadline may cause it to default on its loans. It is seeking a one-month extension to file results.
“The company currently does not anticipate being able to meet the report deadlines,” the company says in an SEC filing on Friday. “As a result, the company expects to engage in discussions with the lenders under the credit agreement and the holders of the notes regarding extending the report deadlines to Aug. 31, 2016 (for the SEC reports as well as the report for the quarter ended June 30, 2016) and waiving until Aug. 31, 2016, any defaults or events of default that would otherwise occur due to the failure to timely provide such reports.”
21st Century says it expects to report total revenues of between $1.07 billion and $1.09 billion in 2015. For the first quarter, the company expects to report between $264 million and $281 million in revenues, the SEC filing says.
Fort Myers-based 21st Century Oncology operates 181 treatment centers, including 145 centers in 17 U.S. states and 36 in seven Latin American countries.
Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.
